Cited by 251Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchRetinal Diseases and Treatments

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study

Open access
Gong, Q., Gregg, E. W., Wang, J., An, Y., Zhang, P., Yang, W., Li, H., Li, H., Jiang, Y., Shuai, Y., Zhang, B., Zhang, J., Gerzoff, R. B., Roglic, G., Hu, Y., Li, G., Bennett, P. H.·2011·Diabetologia

Abstract

Aims/hypothesis We determined the effects of 6 years of lifestyle intervention in persons with impaired glucose tolerance (IGT) on the development of retinopathy, nephropathy and neuropathy over a 20 year period.Methods In 1986, 577 adults with IGT from 33 clinics in Da Qing, China were randomly assigned by clinic to a control group or one of three lifestyle intervention groups (diet, exercise, and diet plus exercise). Active intervention was carried out from 1986 to 1992. In 2006 we conducted a 20 year follow-up study of the original participants to compare the incidence of microvascular complications in the combined intervention group vs the control group.Results Follow-up information was obtained on 542 (94%) of the 577 original participants. The cumulative incidence of severe retinopathy was 9.2% in the combined intervention group and 16.2% in the control group (p = 0.03, log-rank test). After adjusting for clinic and age, the incidence of severe retinopathy was 47% lower in the intervention group than the control group (hazard rate ratio 0.53, 95% CI 0.29-0.99, p = 0.048). No significant differences were found in the incidence of severe nephropathy (hazard rate ratio 1.05, 95% CI 0.16-7.05, intervention vs control, p = 0.96) or in the prevalence of neuropathy (8.6% vs 9.1%, p = 0.89) among the 20 year survivors.Conclusions/interpretation Lifestyle intervention for 6 years in IGT was associated with a 47% reduction in the incidence of severe, vision-threatening retinopathy over a 20 year interval, primarily due to the reduced incidence of diabetes in the intervention group. However, similar benefits were not seen for nephropathy or neuropathy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-010-1948-9

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 32 references

Research works printed but not linked: 1

  1. Anonymous (1985) Diabetes mellitus Report of a WHO Study Group. World Health Organ Tech Rep Ser 727:1–113

Cited by

Sorted by citations

Items 101–200 of 251

Metadata

Authors
Gong, Q., Gregg, E. W., Wang, J., An, Y., Zhang, P., Yang, W., Li, H., Li, H., Jiang, Y., Shuai, Y., Zhang, B., Zhang, J., Gerzoff, R. B., Roglic, G., Hu, Y., Li, G., & Bennett, P. H.
Affiliations
  • China-Japan Friendship Hospital (CN)
  • Centers for Disease Control and Prevention (US)
  • Daqing Oilfield General Hospital (CN)
  • National Institutes of Health (US)
Corresponding author
Li, G.
Venue
Diabetologia
Published
2010-11-03
Volume
54
Issue
2
Pages
300-307
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2067941747
Cited by
251
References
32
Citations by year
2026: 7 · 2025: 13 · 2024: 14 · 2023: 12 · 2022: 15 · 2021: 11 · 2020: 12 · 2019: 16 · 2018: 20 · 2017: 17 · 2016: 18 · 2015: 29 · 2014: 25 · 2013: 22 · 2012: 14
FWCI
10.13
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
  • American Diabetes Association
  • Centers for Disease Control and Prevention (U58/CCU424123‐01‐02)
  • U.S. Public Health Service (U58/CCU424123-01-02)
  • China-Japan Friendship Hospital
  • National Institute of Diabetes and Digestive and Kidney Diseases
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
impaired glucose tolerance, lifestyle intervention, diabetes prevention, diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, microvascular complications, diet and exercise, long-term follow-up
MeSH terms
Adult, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Female, Humans, Life Style, Male, Middle Aged, Glucose Intolerance, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review